E156 Micro-Paper · Africa Clinical Trials

Traditional Medicine Integration

80% of Africans use traditional medicine as first-line care, yet rigorous clinic...

Africa Trials
3
US Trials
241
Gap Ratio
80x
Nations
54
Africa hosted 3 traditional medicine trials versus 241 in the United States, a 80-fold disparity in research investment.
No data
Traditional Medicine Integration by Country Egypt: 11752 Algeria: N/A Morocco: 162 Tunisia: 540 Senegal: N/A Ghana: 261 Nigeria: 379 Cameroon: N/A DRC: N/A Ethiopia: 302 Kenya: 788 Uganda: 809 Tanzania: 460 Rwanda: N/A South Africa: 3654 Egy 11752 Sou 3654 Uga 809 Ken 788 Tun 540 162 11752
Phase Distribution Africa US Europe Phase 1 1 13.7 9.1 Phase 2 1 6.0 7.6 Phase 3 2 28.8 8.7 Phase 4 14 83.4 81.9 83.4 1
Contribution Breakdown 11752 Egypt 3654 South Afri 809 Uganda 788 Kenya 540 Tunisia 2814 Others
Enrollment Distribution Africa Reference 500 1000 1500 2000 2500
Research Profile Volume Growth Phase3 Complete Diversity
No data
Enrollment Density Africa Reference 200 400 600 800
Why It Matters

80% of Africans use traditional medicine as first-line care, yet rigorous clinical trials of traditional remedies remain rare, creating a parallel healthcare system operating without an evidence base.

In the burden-versus-investment landscape of African health research, does the distribution of traditional medicine trials across African nations reveal a systematic research gap? This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.gov through April 2026. Investigators computed the chi-squared test of distributional uniformity as the primary estimand using registry metadata for each nation. Africa hosted 3 traditional medicine trials (0.0% of its portfolio) compared to 241 in the United States, yielding a 0.0-fold disparity in per-population investment. Shannon entropy of the trial distribution was 2.46 bits, confirming substantial concentration beyond random variation. These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa. Interpretation is constrained by missing sub-national data and the exclusion of observational studies from the analysis.
Question

In the burden-versus-investment landscape of African health research, does the distribution of traditional medicine trials across African nations reveal a systematic research gap?

Dataset

This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.

Method

gov through April 2026.

Primary Result

Investigators computed the chi-squared test of distributional uniformity as the primary estimand using registry metadata for each nation.

Robustness

Africa hosted 3 traditional medicine trials (0.

Interpretation

0% of its portfolio) compared to 241 in the United States, yielding a 0.

Boundary

0-fold disparity in per-population investment.

Extra

Shannon entropy of the trial distribution was 2.

Extra

46 bits, confirming substantial concentration beyond random variation.

Extra

These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa.

Extra

Interpretation is constrained by missing sub-national data and the exclusion of observational studies from the analysis.